- Corporate Officers - H
- Hastings Paul J
Insider Trading History of Hastings Paul J
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hastings Paul J since 2015.
This trader's CIK number is 1309702.
At the time of last reporting, Hastings Paul J was the Chief Executive Officer of Nkarta, Inc.. (stock ticker symbol NKTX).
Also see all insider trading activities at Nkarta, Inc..
Note that in the past
HASTINGS PAUL J also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Nkarta, Inc. (NKTX) by Hastings Paul J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | NKTX | 0 | $0 | 19,168 | $41,435 | 0 | $0 |
| 2024 | NKTX | 0 | $0 | 11,467 | $94,663 | 0 | $0 |
| 2023 | NKTX | 0 | $0 | 5,395 | $28,527 | 0 | $0 |
| 2022 | NKTX | 0 | $0 | 6,126 | $79,717 | 0 | $0 |
| 2021 | NKTX | 0 | $0 | 25,500 | $759,211 | 0 | $0 |
Yearly summary of insider trading at Relypsa Inc (RLYP) by Hastings Paul J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | RLYP | 0 | $0 | 1,013 | $19,573 | 0 | $0 |
| 2015 | RLYP | 0 | $0 | 1,454 | $50,359 | 0 | $0 |
Yearly summary of insider trading at Oncomed Pharmaceuticals Inc (OMED) by Hastings Paul J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | OMED | 0 | $0 | 50,609 | $420,522 | 42,738 | $61,114 |
| 2016 | OMED | 0 | $0 | 2,412 | $52,875 | 0 | $0 |
Yearly summary of insider trading at Pacira Biosciences, Inc. (PCRX) by Hastings Paul J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | PCRX | 0 | $0 | 880 | $24,974 | 0 | $0 |
| 2023 | PCRX | 0 | $0 | 7,580 | $315,186 | 7,000 | $209,300 |
| 2022 | PCRX | 0 | $0 | 533 | $30,354 | 0 | $0 |
| 2021 | PCRX | 0 | $0 | 3,000 | $197,640 | 3,000 | $41,940 |
| 2020 | PCRX | 0 | $0 | 2,025 | $96,106 | 0 | $0 |
| 2019 | PCRX | 0 | $0 | 782 | $33,360 | 0 | $0 |
| 2018 | PCRX | 0 | $0 | 771 | $26,136 | 0 | $0 |
| 2017 | PCRX | 0 | $0 | 1,044 | $37,740 | 0 | $0 |
| 2016 | PCRX | 0 | $0 | 4,136 | $233,335 | 3,000 | $37,185 |
| 2015 | PCRX | 0 | $0 | 11,000 | $815,210 | 11,000 | $134,760 |
Insider trading activities at 4 companies by Hastings Paul J:
1. Nkarta, Inc. (NKTX)
2. Relypsa Inc (RLYP)
3. Oncomed Pharmaceuticals Inc (OMED)
4. Pacira Biosciences, Inc. (PCRX)
Table 1. Insider trading of Nkarta, Inc. (NKTX) by Hastings Paul J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-06-18 | NKTX | Sale | 1,790 | 1.79 | 3,204 |
| 2025-01-15 | NKTX | Sale | 17,378 | 2.20 | 38,231 |
| 2024-06-18 | NKTX | Sale | 1,770 | 5.60 | 9,912 |
| 2024-01-16 | NKTX | Sale | 9,697 | 8.74 | 84,751 |
| 2023-06-20 | NKTX | Sale | 1,704 | 4.85 | 8,264 |
| 2023-01-17 | NKTX | Sale | 3,691 | 5.49 | 20,263 |
| 2022-09-21 | NKTX | Sale | 6,126 | 13.01 | 79,717 |
| 2021-09-29 | NKTX | Sale | 8,500 | 26.86 | 228,352 |
| 2021-03-30 | NKTX | Sale | 17,000 | 31.23 | 530,859 |
Table 2. Insider trading of Relypsa Inc (RLYP) by Hastings Paul J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-06-07 | RLYP | Sale | 1,013 | 19.32 | 19,573 |
| 2015-06-11 | RLYP | Sale | 1,454 | 34.63 | 50,359 |
Table 3. Insider trading of Oncomed Pharmaceuticals Inc (OMED) by Hastings Paul J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-10-10 | OMED | Sale | 1,398 | 4.25 | 5,942 |
| 2017-04-04 | OMED | Sale | 6,473 | 8.96 | 58,017 |
| 2017-01-06 | OMED | Sale | 21,369 | 8.52 | 181,957 |
| 2017-01-05 | OMED | Sale | 21,369 | 8.17 | 174,606 |
| 2017-01-06 | OMED | Option Ex | 21,369 | 1.43 | 30,557 |
| 2017-01-05 | OMED | Option Ex | 21,369 | 1.43 | 30,557 |
| 2016-01-06 | OMED | Sale | 2,412 | 21.92 | 52,875 |
Table 4. Insider trading of Pacira Biosciences, Inc. (PCRX) by Hastings Paul J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-06-13 | PCRX | Sale | 880 | 28.38 | 24,974 |
| 2023-06-05 | PCRX | Sale | 580 | 38.34 | 22,236 |
| 2023-05-15 | PCRX | Option Ex | 7,000 | 29.90 | 209,300 |
| 2023-05-15 | PCRX | Sale | 7,000 | 41.85 | 292,950 |
| 2022-07-11 | PCRX | Sale | 533 | 56.95 | 30,354 |
| 2021-03-05 | PCRX | Option Ex | 3,000 | 13.98 | 41,940 |
| 2021-03-05 | PCRX | Sale | 3,000 | 65.88 | 197,640 |
| 2020-06-04 | PCRX | Sale | 2,025 | 47.46 | 96,106 |
| 2019-06-04 | PCRX | Sale | 782 | 42.66 | 33,360 |
| 2018-06-04 | PCRX | Sale | 771 | 33.90 | 26,136 |
| 2017-08-22 | PCRX | Sale | 1,044 | 36.15 | 37,740 |
| 2016-06-06 | PCRX | Sale | 1,136 | 46.95 | 53,335 |
| 2016-02-17 | PCRX | Option Ex | 3,000 | 12.39 | 37,185 |
| 2016-02-17 | PCRX | Sale | 3,000 | 60.00 | 180,000 |
| 2015-11-20 | PCRX | Option Ex | 3,000 | 10.81 | 32,430 |
| 2015-11-20 | PCRX | Sale | 3,000 | 60.00 | 180,000 |
| 2015-08-17 | PCRX | Option Ex | 3,000 | 10.81 | 32,430 |
| 2015-08-17 | PCRX | Sale | 3,000 | 60.02 | 180,060 |
| 2015-04-10 | PCRX | Option Ex | 2,500 | 13.98 | 34,950 |
| 2015-04-10 | PCRX | Sale | 2,500 | 88.00 | 220,000 |
| 2015-01-12 | PCRX | Option Ex | 2,500 | 13.98 | 34,950 |
| 2015-01-12 | PCRX | Sale | 2,500 | 94.06 | 235,150 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Hastings Paul J
(Chief Executive Officer of Nkarta, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.